(1)
Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-Small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?. Can Oncol Today 2025, 2 (1), 13–17. https://doi.org/10.58931/cot.2025.2131.